In this episode, we sit down with Dr. Alison MacBeth, a breast specialty doctor and a British Menopause Society accredited menopause specialist, to discuss a topic often considered taboo: hormone replacement therapy (HRT) for breast cancer survivors.

Dr. MacBeth shares her journey from family physician to a trailblazer in this field. We explore the traditional thinking behind why HRT is deemed "off-limits" for breast cancer patients, including a deep dive into the historical "Habits" and "Stockholm" trials.

This conversation is a must-listen for anyone seeking to understand the latest evidence on HRT, the importance of shared decision-making with your doctor, and the difference between various types of HRT, including the exciting new data on Duavee from the PROMISE Study. Dr. MacBeth also provides invaluable advice on managing debilitating menopause symptoms and the critical role of vaginal estrogen.

Show Notes:

• Recommended Read: Navigating Menopause After Cancer - available on Amazon, by Danni Binnington with input from Dr Macbeth
• Menopause and Cancer Charity: Learn more about this invaluable resource at https://www.menopauseandcancer.org.
• The Menopause Society: Find a provider in the US at https://www.menopause.org.
• Canadian Menopause Society: Information and resources for women in Canada at https://www.google.com/search?q=https://www.menopause.ca.
• British Menopause Society: Resources for the UK at https://thebms.org.uk.

#HRT #HormoneReplacementTherapy #BreastCancer #Menopause #MenopauseSymptoms #Estrogen #Oestrogen #Progesterone #Duavee #Tamoxifen #AromataseInhibitors #Urosepsis #VaginalDryness #TheMenopauseSociety #BreastCancerSurvivor #DrAlisonMacBeth #WomensHealth #Oncology #CancerTreatment #InformedChoice